Hints and tips:
Related Special Reports
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...Timothy Mackey, professor of global health at University of California San Diego, predicted that other pharma companies would probably follow Eli Lilly and Pfizer....
...Pfizer is “trying to leverage some of that brand equity that they got the world spinning again”, said Markus Saba, a marketing professor at the University of North Carolina Center for the Business of Health...
...Novavax shares closed 98.7 per cent higher on Friday in New York at $8.88, moderating from a gain of as much as 146 per cent earlier in the session, following the announcement....
.... — Lee Harris shareholder proposals Health risks in focus at annual meetings At their annual meetings today, Coca-Cola and Pepsi will hold votes on shareholder resolutions on health risks — part of a...
...But it will be companies with large health insurance divisions such as UnitedHealth not traditional retailers, that will have the best shot at capturing more of that $4.5tn pie. pan.yuk@ft.com...
...J&J was valued at $367bn, as of market close in New York on Thursday....
...Cuban is targeting the 38 per cent of private sector employers who self-insure at least one of their health plans....
...Meanwhile, PMI’s reputation is bedevilling its efforts to diversify into health products....
...insurance scheme],” said Robert Przybelski, a geriatrician at UW Health in Madison, Wisconsin, where about 25 patients have been treated with the drug....
...Valued at more than $40bn at the height of the pandemic in early 2021, Novavax made a series of mis-steps with the launch of its Covid vaccine....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...“Some companies probably thought that shock was going to be permanent,” said Steven Blitz, chief US economist at TS Lombard. “Now they’re getting a painful bounceback from that.”...
...The researchers concluded that “the medicines are so expensive they are essentially unavailable unless reimbursed by government or health system authorities”....
...Shagun Singh, an analyst at RBC Capital Markets, said in a note that she was “encouraged” by J&J’s proposed plan “which removes one aspect of overhang on the stock”....
...I’ve got another meeting with Wes Streeting and Peter Kyle about AI in the health service tomorrow. Feel like I am making headway....
...“We’re positioning the company for the long-term health of the business and the market doesn’t necessarily operate that way,” she said....
...On a busy day at work in 2016, Matthew Panuwat took a break from his biotech executive job to make a stock trade on his computer....
...Except, apparently, at the European consumer giant Unilever....
...A US appeals court has allowed a sales ban on Apple’s Watch Series 9 and Ultra 2 to resume, the latest setback in the technology giant’s dispute with health technology company Masimo over patents for its...
...In the UK, annual sickness absence rates are at their highest levels in more than a decade, at an average of 7.8 days per employee, says the Chartered Institute of Personnel and Development....
...At its peak in 2021, Pfizer traded at $61 a share. The share price is now less than half that. Demand for Covid shots has collapsed....
...(The bonds were trading at 89c on the dollar at the end of February, according to Finra data.) Whoops!...
...“There have been fewer LBOs and therefore less new loan volume,” said Michael Patterson, a governing partner at asset manager HPS Investment Partners....
...Join Nancy Pelosi, Jake Sullivan, actor Bradley Whitford and holistic health practitioner Eileen Moran at the FT Weekend Festival tomorrow in Washington DC....
International Edition